MRK
Toronto Stock ExchangeMerck CDR (CAD Hedged)
Common Stock
$24.50
CAD
+0.00 (%)
Last updated: 1/8/2026
Price Chart (30 Days)
Key Statistics
Market Cap
$264.21B
52W High
$25.30
52W Low
$16.37
P/E Ratio
11.75
50 Day MA
$0.00
200 Day MA
$0.00
Beta
-
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 1/8/2026 | $25.00 | $25.30 | $24.77 | $25.30 | 3,684 |
| 1/7/2026 | $24.85 | $25.10 | $24.40 | $24.50 | 1,832 |
| 1/6/2026 | $24.51 | $24.75 | $24.51 | $24.61 | 9,905 |
| 1/5/2026 | $24.38 | $24.38 | $24.12 | $24.23 | 5,172 |
| 1/2/2026 | $23.77 | $24.03 | $23.67 | $24.02 | 8,042 |
| 12/31/2025 | $24.00 | $24.00 | $23.75 | $23.75 | 528 |
| 12/30/2025 | $24.07 | $24.07 | $24.07 | $24.07 | 150 |
| 12/29/2025 | $24.02 | $24.16 | $24.02 | $24.11 | 4,682 |
| 12/24/2025 | $23.76 | $24.11 | $23.76 | $24.11 | 519 |
About Merck CDR (CAD Hedged)
Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and anti-PD-1 therapy, as well as KEYTRUDA (pembrolizumab) in patients with advanced solid tumors. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Financials
- Revenue (TTM)
- $0
- EBITDA
- -
- Profit Margin
- 0.00%
- ROE (TTM)
- 3950.93%
- EPS (Diluted)
- 0.00
- Book Value
- -
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE Report